光大证券(06178.HK)全资子公司遭入禀索近35亿人币
光大证券(06178.HK)公布,全资子公司光大资本近日收到上海金融法院应诉通知书,浸鑫基金中一家优先级合夥人之利益相关方招商银行(03968.HK)作为原告,因前述公告中提及的《差额补足函》相关纠纷,对光大资本提起诉讼,要求光大资本履行相关差额补足义务,诉讼金额约34.89亿元人民币(下同)。
公司指,目前本案尚处於立案受理阶段,对光大资本的影响暂无法准确估计。目前因相关事项,光大资本及其子公司经自查发现名下相关银行账户、股权及基金份额已被申请财产保全,涉及相关银行账户资金约为57.76万元,相关投资成本约为43.88亿元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.